Mark Lazarev

4.3k citations

65 papers · 1.9k indexed · 1 hit paper · h-index 22

Impact in

Gastroenterology top 5%
Genetics top 5%
- Inflammatory Bowel Disease

Papers in

Genetics 44
- Inflammatory Bowel Disease 43
Epidemiology 32
- Microscopic Colitis 27
- Autoimmune and Inflammatory Disorders 9

Co-authors: Steven R. Brant Alyssa Parian Annemarie Boleij Emilia Albesiano Elizabeth A. Platz Elizabeth C. Wick Ellen M. Stein Elizabeth M. Hechenbleikner
Journals: Gastroenterology (18 papers)Inflammatory Bowel Diseases (6 papers)The American Journal of Gastroenterology (5 papers)Journal of Crohn s and Colitis (3 papers)Digestive Diseases and Sciences (3 papers)
Partner nations: United States Canada China

In The Last Decade

Mark Lazarev

63 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

The Bacteroides fragilis Toxin Gene Is Prevalent in the Colon Mucosa of Colorectal Cancer Patients 2014 · 453 citations

Peers

Countries citing papers authored by Mark Lazarev

Since Specialization

Citations

This map shows the geographic impact of Mark Lazarev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lazarev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lazarev more than expected).

Fields of papers citing papers by Mark Lazarev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lazarev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lazarev. The network helps show where Mark Lazarev may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Lazarev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Lazarev Line = papers co-authored together Mark Lazarev links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MOBILE ROBOT MOTION CONTROL FOR DIFFERENT PATHS ON THE BASIS OF THE PRINCIPLE OF REDUCTION OF THE THEORY OF FUZZER Bulletin of Belgorod State Technological University named after V G Shukhov ·Mark Lazarev, 伊佐地隆	2023	0
2	A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn’s Disease Recurrence Journal of Crohn s and Colitis ·Xiaolian Dong, Shadi Nayeri, Jiayi Ji, Cristian Hernández-Rocha, A. Lacaze, Liangyuan Hu, Mamta Giri, Shikha Nayar, Steven R. Brant, Dermot McGovern, John D. Rioux, Richard H. Duerr, Judy H. Cho, L. Philip Schumm, Mark Lazarev, Mark S. Silverberg	2021	15
3	Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease–associated colorectal neoplasia Human Pathology ·Aatur D. Singhi, Kevin Waters, John Joseph Kerigan, Alyssa Parian, Mark Lazarev, Siobhan Proksell, Jeffrey Dueker, Marc Schwartz, Abigail I. Wald, Marina N. Nikiforova, Elizabeth A. Montgomery	2021	14
4	Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA Digestive Diseases and Sciences ·Peiqi Wang, Jun Hu, Catherine Delichère, Ana Lídia Prates, Douglas O’Connell, Amy Xiao, María Luisa Jiménez-Rodrigo, Min Zhi, Yuanqi Zhang, Nimisha Parekh, Mark Lazarev, Alyssa Parian, Steven R. Brant, Marshall Bedine, Brindusa Truta, P. Hu, Rupa Banerjee, Susan Hutfless	2018	28
5	Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus–encoded small RNA1 in situ hybridization Human Pathology ·Maryam Kherad Pezhouh, James A. Miller, Rajni Sharma, Alberto Balaguer Gómez, Intermaher, Kevin Waters, Maria Westerhoff, Alyssa Parian, Mark Lazarev, Lysandra Voltaggio	2018	18
6	Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis Gastrointestinal Endoscopy ·Marietta Iacucci, Marco Daperno, Mark Lazarev, P.D. McLean, Gian Eugenio Tontini, Niu Chun-ya, Xianyong Gui, Vincenzo Villanacci, Martin Goetz, Mark Lowerison, Brendan Cord Lethebe, Maurizio Vecchi, Helmut Neumann, Subrata Ghosh, Raf Bisschops, Ralf Kießlich	2017	59
7	Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease Digestive Diseases and Sciences ·Swathi Eluri, Alyssa Parian, Berkeley N. Limketkai, Christina Ha, Steven R. Brant, Sharon Dudley‐Brown, Jonathan E. Efron, HU Kerl, Susan L. Gearhart, Michael R. Marohn, Stephen J. Meltzer, Mukharjee S. S. Madivada, Brindusa Truta, Elizabeth A. Montgomery, Mark Lazarev	2017	21
8	Family history and disease outcomes in patients with Crohn’s disease: A comparison between China and the United States World Journal of Gastrointestinal Pharmacology and Therapeutics ·Peiqi Wang, Jun Hu, Gamaleldin Hussein, ez Israel Morales-Sánchez, Min Zhi, Xiang Gao, Duyen Anh, Sami Ghazaleh, F.F. Chen, Kashyap Krishnan P., Catherine Delichère, H.A. González, Mark Lazarev, P. Hu, Susan Hutfless	2016	11
9	The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans Journal of Crohn s and Colitis ·Ling Liu, Ying Dong, Mei Ye, Shi Jin, Jianbo Yang, Maria E. Joosse, Yu Sun, Jennifer Zhang, Mark Lazarev, Steven R. Brant, Bashar Safar, Michael R. Marohn, Esteban Mezey, Xuhang Li	2016	160
10	Who and how to screen for cancer in at-risk inflammatory bowel disease patients Expert Review of Gastroenterology & Hepatology ·Alyssa Parian, Mark Lazarev	2015	14
11	Anti–Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease Inflammatory Bowel Diseases ·Stefan D. Holubar, Jennifer Holder‐Murray, Mark Flasar, Mark Lazarev	2015	25
12	Pharmacologic therapies for the management of Crohn's Disease: comparative effectiveness Zurich Open Repository and Archive (University of Zurich) ·Susan Hutfless, 徐铭湖, Zackary Berger, Lisa M Wilson, Jonna Sipiläinen, Qi Chen, E. Dito, Qi Li, Milo A. Puhan, Salvatore Di Salvo, Anne Tuskey, Jawaher A. Al-Otaibi, Eric B Bass, Mark Worthington, Ghanshyam Shantha, Mark Lazarev	2014	2
13	Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn’s disease medications and hepatosplenic T-cell lymphoma Systematic Reviews ·Salvatore Di Salvo, Anders Mattson Myhrman, Lisa M Wilson, Mark Lazarev, Eric B Bass, Susan Hutfless	2013	15
14	Relationship Between Proximal Crohn's Disease Location and Disease Behavior and Surgery: A Cross-Sectional Study of the IBD Genetics Consortium The American Journal of Gastroenterology ·Mark Lazarev, Chengrui Huang, Alain Bitton, Judy H. Cho, Richard H. Duerr, Dermot McGovern, Deborah D. Proctor, Miguel Regueiro, John D. Rioux, L. Philip Schumm, Kent D. Taylor, Mark S. Silverberg, Roswitha Dolcemascolo, Susan Hutfless, Steven R. Brant	2012	141
15	Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning Endocrine Related Cancer ·Yuriko Mori, Alexandru Olaru, Yulan Cheng, Rachana Agarwal, Jian Yang, Delgermaa Luvsanjav, Wayne Yu, Florin M. Selaru, Susan Hutfless, Mark Lazarev, John H. Kwon, Steven R. Brant, Michael R. Marohn, David F. Hutcheon, Mark D. Duncan, Ajay Goel, Stephen J. Meltzer	2011	63
16	Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers Inflammatory Bowel Diseases ·Alexandru Olaru, Yulan Cheng, Rachana Agarwal, Jian Yang, Stefan David, John Abraham, Wayne Yu, John H. Kwon, Mark Lazarev, Steven R. Brant, Michael R. Marohn, David F. Hutcheon, Noam Harpaz, Stephen J. Meltzer, Yuriko Mori	2011	25
17	Small bowel resection rates in Crohnʼs disease and the indication for surgery over time: Experience from a large tertiary care center Inflammatory Bowel Diseases ·Mark Lazarev, Thomas Ullman, Wolfgang H. Schraut, Kevin E. Kip, Melissa Saul, Miguel Regueiro	2009	72
18	S2091 Does the Pain-Protective GTP Cyclohydrolase Haplotype Significantly Alter the Severity of Pain in Humans with Chronic Pancreatitis? Gastroenterology ·Mark Lazarev, Janette Lamb, M. Michael Barmada, David C. Whitcomb	2008	5
19	Hemispheric Activation of Anterior and Inferior Prefrontal Cortex during Verbal Encoding and Recognition: A PET Study of Healthy Volunteers NeuroImage ·J. Daniel Ragland, Ruben C. Gur, Mark Lazarev, Robin J. Smith, Lee Schroeder, Jonathan Raz, Bruce I. Turetsky, Abass Alavi, Raquel E. Gur	2000	28
20	Frontotemporal cerebral blood flow change during executive and declarative memory tasks in schizophrenia: A positron emission tomography study. Neuropsychology ·J. Daniel Ragland, Ruben C. Gur, David C. Glahn, David M. Censits, Robin Smith, Mark Lazarev, J. Kabel, Raquel E. Gur	1998	86

About Mark Lazarev

Mark Lazarev is a scholar working on Genetics, Epidemiology, Gastroenterology, Surgery and Oncology, having authored 65 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (43 papers), Microscopic Colitis (27 papers), Autoimmune and Inflammatory Disorders (9 papers), Eosinophilic Esophagitis (8 papers), Colorectal Cancer Screening and Detection (5 papers), Genetic factors in colorectal cancer (5 papers), Gastrointestinal disorders and treatments (4 papers) and Diverticular Disease and Complications (4 papers). The work is most often cited by research in Gastroenterology (144 citations), Genetics (677 citations), Epidemiology (555 citations), Oncology (432 citations) and Surgery (473 citations). Mark Lazarev has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Steven R. Brant, Alyssa Parian, Annemarie Boleij, Emilia Albesiano, Elizabeth A. Platz, Elizabeth C. Wick, Ellen M. Stein, Elizabeth M. Hechenbleikner, Andrew C. Goodwin and Drew M. Pardoll. Their work appears in journals such as Gastroenterology, Inflammatory Bowel Diseases, The American Journal of Gastroenterology, Journal of Crohn s and Colitis and Digestive Diseases and Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact